PLSE

Pulse Biosciences, Inc.

Healthcare
Medical - Instruments & Supplies
$3.78B market cap

Forecast run · Oct 29, 2026Upside rank 521 of 3,186

Model Signal

ForecastQ Daily Probabilities

44.7%

64.8%

36.6%

Analyst Consensus

Recommendation2.33/5 Buy

Last price$53.02

Price target$60.20

Implied move+13.5%

Analysts6

ForecastQ Portfolios

PLSE is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.